Santa Monica, CA, United States of America

Charles Louis Wiseman

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Charles Louis Wiseman: Innovator in Cancer Vaccine Technology

Introduction

Charles Louis Wiseman is a notable inventor based in Santa Monica, CA. He has made significant contributions to the field of cancer treatment through his innovative work on whole-cell cancer vaccines. His research focuses on enhancing the effectiveness of cancer therapies, providing hope for patients battling this disease.

Latest Patents

Wiseman holds a patent for "Whole-cell cancer vaccines and methods for selection thereof." This invention provides a modified human cancer cell that comprises a recombinant polynucleotide encoding an allele of a human leukocyte antigen gene. The patent also outlines methods for selecting a whole-cell cancer vaccine for subjects with cancer and methods of treating cancer using these vaccines. Additionally, it includes a method for determining the HER2 status of a cell, along with compositions and kits related to the invention.

Career Highlights

Wiseman is associated with Briacell Therapeutics Corp., a company dedicated to developing innovative cancer therapies. His work at Briacell has positioned him as a key player in the advancement of cancer treatment technologies. His dedication to research and development has led to breakthroughs that could change the landscape of cancer care.

Collaborations

Some of his notable coworkers include Markus Daniel Lacher and Joseph Paul Wagner. Their collaborative efforts contribute to the ongoing research and development of effective cancer treatments.

Conclusion

Charles Louis Wiseman's contributions to cancer vaccine technology exemplify the impact of innovative thinking in medicine. His work continues to inspire advancements in cancer treatment, offering new hope to patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…